Oceanic Investment Management LTD Cut Its Hoegh Lng Partners LP (HMLP) Position; 2 Analysts Covering Premaitha Health PLC (LON:NIPT)

December 11, 2017 - By Michael Collier

Among 2 analysts covering Premaitha Health Plc (LON:NIPT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Premaitha Health Plc had 43 analyst reports since September 22, 2015 according to SRatingsIntel. The firm has “Corporate” rating given on Wednesday, March 9 by FinnCap. The stock has “Corporate” rating by FinnCap on Friday, June 16. The company was maintained on Tuesday, November 21 by FinnCap. FinnCap maintained the stock with “Corporate” rating in Monday, November 21 report. The firm has “Buy” rating given on Friday, January 15 by Panmure Gordon. The company was maintained on Wednesday, December 2 by Panmure Gordon. The company was maintained on Monday, April 11 by FinnCap. The rating was maintained by Panmure Gordon on Thursday, November 12 with “Buy”. The firm has “Buy” rating given on Wednesday, October 28 by Panmure Gordon. FinnCap maintained it with “Corporate” rating and GBX 20 target in Friday, September 30 report. See Premaitha Health PLC (LON:NIPT) latest ratings:

11/12/2017 Broker: FinnCap Rating: Corporate Maintain
27/11/2017 Broker: FinnCap Rating: Corporate Maintain
21/11/2017 Broker: FinnCap Rating: Corporate Maintain
29/09/2017 Broker: FinnCap Rating: Corporate Maintain
24/08/2017 Broker: FinnCap Rating: Corporate Maintain
12/07/2017 Broker: FinnCap Rating: Corporate Maintain
16/06/2017 Broker: FinnCap Rating: Corporate Maintain

Oceanic Investment Management Ltd decreased Hoegh Lng Partners Lp (HMLP) stake by 5.38% reported in 2017Q2 SEC filing. Oceanic Investment Management Ltd sold 56,644 shares as Hoegh Lng Partners Lp (HMLP)’s stock declined 1.29%. The Oceanic Investment Management Ltd holds 995,890 shares with $19.07 million value, down from 1.05M last quarter. Hoegh Lng Partners Lp now has $347.74 million valuation. The stock increased 0.82% or $0.1438 during the last trading session, reaching $17.5938. About 89,219 shares traded or 23.51% up from the average. Höegh LNG Partners LP (NYSE:HMLP) has risen 10.34% since December 11, 2016 and is uptrending. It has underperformed by 6.36% the S&P500.

Among 6 analysts covering Hoegh LNG Partners LP (NYSE:HMLP), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Hoegh LNG Partners LP had 14 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Höegh LNG Partners LP (NYSE:HMLP) has “Overweight” rating given on Tuesday, July 18 by Barclays Capital. On Thursday, September 7 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm has “Buy” rating given on Thursday, July 20 by Stifel Nicolaus. On Friday, August 25 the stock rating was maintained by Citigroup with “Buy”. The firm has “Buy” rating given on Friday, August 26 by Citigroup. The rating was initiated by Seaport Global Securities on Wednesday, January 6 with “Accumulate”. The rating was upgraded by Morgan Stanley on Wednesday, November 2 to “Overweight”. The stock has “Buy” rating by Clarkson Capital on Wednesday, September 9. As per Thursday, October 12, the company rating was maintained by Stifel Nicolaus. Stifel Nicolaus initiated it with “Buy” rating and $22 target in Monday, December 12 report.

It closed at GBX 5.625 lastly. It is up 0.00% since December 11, 2016 and is . It has underperformed by 16.70% the S&P500.

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company has market cap of 18.07 million GBP. The firm develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate DownÂ’s syndrome, EdwardÂ’s syndrome, and PatauÂ’s syndrome. It currently has negative earnings. The IONA test is a diagnostic system that enables clinical laboratory clients to perform the test in their own facilities.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>